Primerica (PRI) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
27 Jun, 2026Opening remarks and agenda
Meeting called to order by the Chairman, with all directors and senior executives introduced and present by phone or in person.
Inspector of Elections and independent auditors from KPMG introduced.
Quorum established with at least 90% of outstanding shares represented.
Agenda and meeting procedures distributed to all participants.
Board and executive committee updates
Eleven director nominees presented for election, with information and board recommendations provided in the proxy statement.
No additional nominations or proposals received beyond those in the proxy statement.
Overview of voting outcomes
Over 90% of votes cast in favor of electing all 11 director nominees.
Over 96% of votes in favor of executive compensation on an advisory basis.
Over 99% of votes in favor of ratifying KPMG as independent auditor for 2025.
Final results to be filed in a Form 8-K with the SEC and posted online.
Latest events from Primerica
- Q3 2024 net income from continuing operations rose 24% on 11% revenue growth.PRI
Q3 20249 Jul 2026 - All proposals passed with strong support; two board seats remain vacant pending new appointments.PRI
AGM 202629 Jun 2026 - Record ISP sales drove 9% revenue growth and 19% higher EPS, with strong capital returns.PRI
Q1 20268 May 2026 - Record ISP sales and asset growth fueled double-digit earnings and capital returns.PRI
Q4 202513 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the 2026 annual meeting.PRI
Proxy filing2 Apr 2026 - Solid 2025 results, strong governance, and enhanced ESG drive board and pay proposals.PRI
Proxy filing2 Apr 2026 - Record 2025 financials and robust capital returns highlight scalable growth and strong risk management.PRI
Investor presentation25 Mar 2026 - Record ISP sales and 8% revenue growth drove higher earnings and capital returns.PRI
Q3 20253 Feb 2026 - Adjusted EPS up 18% and record sales force, despite Senior Health exit and impairment.PRI
Q2 20242 Feb 2026